A new study published in Clinical Cardiology introduces the North Indian (NORIN) ST‐Segment Elevation Myocardial Infarction (STEMI) Registry and provides preliminary data collected since its start in ...
San Francisco, CA—Results of the randomized EUROMAX trial show that administering bivalirudin to STEMI patients en route to the hospital for primary PCI reduces the primary outcome of short-term death ...
Please provide your email address to receive an email when new articles are posted on . A comprehensive focus on STEMI care that includes transradial primary PCI, prompt guideline-directed medical ...
February is Heart Health Awareness Month, and it is an opportune time to shed light on a critical issue that can affect rural communities like Humboldt County — the urgent need for STEMI (ST-Elevation ...
A new study from Denmark conducted over a 16-year period shows a 30% reduction in the 1-year mortality rate following percutaneous coronary intervention (PCI) for ST-segment elevation myocardial ...
CHICAGO -- Periprocedural anticoagulation with bivalirudin (Angiomax) for a radial-first approach to primary percutaneous coronary intervention (PCI) improved mortality and bleeding risk compared with ...
Many fewer Americans are falling prey to the most dangerous form of heart attack, a new study says. STEMI (ST‐segment-elevation myocardial infarction) heart attacks have declined by nearly 50% during ...
Morton Kern, MD, of VA Long Beach Healthcare System and University of California, Irvine, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in ...
Introduction Ischaemic heart disease (IHD) remains a leading cause of morbidity and mortality worldwide and poses an ...
It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...
Mineralocorticoid-receptor antagonists (MRAs) have been shown to reduce adverse cardiovascular outcomes in high-risk patients with ST-segment elevation myocardial infarction (STEMI). Preliminary data ...
Powerful Medical, a leader in AI-driven cardiovascular diagnostics, announces that its PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results